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RESEARCH ARTICLE

Auriculocondylar syndrome 2 results from the dominant-negative
action of PLCB4 variants

ABSTRACT
Auriculocondylar syndrome 2 (ARCND2) is a rare autosomal
dominant craniofacial malformation syndrome linked to multiple
genetic variants in the coding sequence of phospholipase C β4
(PLCB4). PLCB4 is a direct signaling effector of the endothelin
receptor type A (EDNRA)-Gq/11 pathway, which establishes the
identity of neural crest cells (NCCs) that form lower jaw and middle ear
structures. However, the functional consequences of PLCB4 variants
on EDNRA signaling is not known. Here, we show, using multiple
signaling reporter assays, that known PLCB4 variants resulting from
missense mutations exert a dominant-negative interference over
EDNRA signaling. In addition, using CRISPR/Cas9, we find that F0
mouse embryos modeling one PLCB4 variant have facial defects
recapitulating those observed in hypomorphic Ednra mouse models,
including a bone that we identify as an atavistic change in the
posterior palate/oral cavity. Remarkably, we have identified a similar
osseous phenotype in a child with ARCND2. Our results identify the
disease mechanism of ARCND2, demonstrate that the PLCB4
variants cause craniofacial differences and illustrate how minor
changes in signaling within NCCs may have driven evolutionary
changes in jaw structure and function.
This article has an associated First Person interview with the first
author of the paper.
KEY WORDS: Craniofacial, G protein, Neural crest cell, CRISPR,
Evolution, Mice

INTRODUCTION

The maxilla, mandible and intervening bone ( jugal/zygoma and
portions of the squamosal bone) are derived from neural crest cells
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(NCCs) that reside in the first pharyngeal arch (Abe et al., 2007;
Chai et al., 2000). First arch NCCs initially possess developmental
plasticity to form either elements of the upper or lower jaw (Barron
et al., 2011; Minoux et al., 2017; Sato et al., 2008; Tavares and
Clouthier, 2015), with those in the mandibular region of first arch
adopting a lower jaw identity through cell-autonomous endothelin
receptor type A (EDNRA) signaling (Clouthier et al., 2003;
Ferguson et al., 2000; Ozeki et al., 2004; Ruest et al., 2004).
Upon binding of its ligand, endothelin 1 (EDN1) (Arai et al., 1990;
Davenport et al., 2016), EDNRA activates the Gq/11 class of
heterotrimeric G proteins in NCCs (Dettlaff-Swiercz et al., 2005;
Ivey et al., 2003; Offermanns et al., 1998). Gq/11 subsequently
activates phospholipase C β (PLCB) isoforms, which, in turn,
convert phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol
1,4,5-triphosphate (IP3) and diacylglycerol (DAG) (Kadamur
and Ross, 2013), resulting in changes in gene expression that
drive NCC patterning. The requirement of EDNRA signaling in
lower jaw development appears conserved in all jawed vertebrates
(Clouthier et al., 2013), including humans (Pritchard et al., 2020),
illustrating that it is a fundamental mechanism that drives facial
development.
There is increasing evidence that a number of gene variants can
disrupt the EDNRA-Gq/11-PLCB4 signaling axis and give rise to
phenotypically distinct human craniofacial disorders. Oro-otocardiac syndrome (OOCS) and mandibulofacial dysostosis with
alopecia (MDFA; MIM 616367) are caused by variants in EDNRA
(MIM 131243), although the variants affect EDNRA function
differently. The OOCS-associated disease variant EDNRA
p.Gln381Pro disrupts receptor-Gq/11 association and abrogates
signaling, leading to cardiac and craniofacial defects resembling the
mouse Ednra knockout phenotype, including neonatal lethality
(Pritchard et al., 2020). The MFDA-associated disease variants
EDNRA p.Tyr129Phe (c.386A>T) and EDNRA p.Glu303Lys
(c.907G>A) likely reduce receptor-EDN1 binding affinity and
increase receptor-EDN3 binding affinity, leading to ectopic
EDNRA signaling in the maxillary prominence (Gordon et al.,
2015). These changes result in defects in the mandible and maxilla,
although cardiovascular development is unaffected.
Distinct from OOCS and MFDA, auriculocondylar syndrome
(ARCND) is a genetically heterogenous disorder primarily caused
by variants in three different signaling proteins that function within
the EDNRA-Gq/11-PLCB signaling pathway. ARCND-associated
variants in GNAI3 (MIM 139370), PLCB4 (MIM 600810) and
EDN1 (MIM 131240) are classified as ARCND1 (MIM 602483),
ARCND2 (MIM 614669) and ARCND3 (MIM 615706),
respectively, with all three types characterized by micrognathia,
temporomandibular joint ankylosis and a stereotypical outer ear
deformity called question mark ears (QME) (Gordon et al., 2013a,b;
Nabil et al., 2020; Rieder et al., 2012; Romanelli Tavares et al.,
2015). Although the ARCND phenotype resembles OOCS and the
1

Disease Models & Mechanisms

Stanley M. Kanai1, Caleb Heffner2, Timothy C. Cox3, Michael L. Cunningham4, Francisco A. Perez5,
Aaron M. Bauer6, Philip Reigan7, Cristan Carter1, Stephen A. Murray2 and David E. Clouthier1,*

RESEARCH ARTICLE

Disease Models & Mechanisms (2022) 15, dmm049320. doi:10.1242/dmm.049320

Ednra mutant mouse phenotype, cardiovascular defects and
neonatal lethality are not observed. The reason for this difference
is still unknown.
The autosomal dominant inheritance and nature of the proteincoding mutations of ARCND1 (GNAI3) and ARCND2 (PLCB4)
have led researchers to hypothesize that dominant-negative
interference of the EDNRA signaling pathway is the underlying
disease mechanism (Clouthier et al., 2013; Gordon et al., 2013b;
Rieder et al., 2012). Indeed, it was demonstrated that GNAI3
variants encode dominant-negative mutants of GNAI3 that form a
nonproductive complex with EDNRA, abrogating EDNRAmediated Gq/11 activation (Marivin et al., 2016). The disease
mechanism for ARCND2 remains to be elucidated.
In this study, we examined the disease mechanism of ARCND2associated PLCB4 variants using in vitro and in vivo approaches.
Using a variety of signaling reporter assays in cell culture, we show
that PLCB4 variants interfere with EDNRA-Gq/11-mediated
activity of wild-type PLCB in a partially dominant-negative
manner, with this interference blocked by disrupting the Gq/11PLCB4 binding interface. Furthermore, using CRISPR/Cas9 gene
editing to model ARCND2 in F0 mice, we find that insertion of a
human PLCB4 variant produces defects resembling those in mouse
models in which EDNRA signaling is reduced, but not lost,
suggesting that ARCND is caused by a partial reduction in EDNRA
signaling. These F0 CRISPR embryos have also allowed us to reinterpret the novel craniofacial differences observed in individuals
with ARCND2. Importantly, one of the observed changes, the
formation of an osseous strut on the lateral pterygoids, resembles the
posterior projection of the pterygoid observed in some nonmammalian amniotes. This likely atavistic change resulting from
low-level EDNRA signaling underscores the flexibility and
sensitivity of NCCs to undergo significant evolutionary change in
response to minor changes in cell signaling pathways.

The majority of PLCB4 variants identified to date in ARCND2
cause missense mutations in the conserved catalytic pocket of
PLCB4 (Gordon et al., 2013b; Nabil et al., 2020; Rieder et al.,
2012), where PIP2 is hydrolyzed into DAG and IP3 (Fig. 1A-C)
(Kadamur and Ross, 2013). Given the functional importance of the
affected residues and the autosomal dominant inheritance of
ARCND2, we and others have hypothesized that these PLCB4
mutants exert a dominant-negative effect on wild-type PLCB
isoforms likely by forming a nonproductive enzyme-substrate
complex with PIP2, leading to insufficient activation of the
EDNRA-Gq/11-PLCB signaling pathway during craniofacial
patterning (Clouthier et al., 2013; Gordon et al., 2013b; Rieder
et al., 2012). To test this, we first created expression plasmids for
ARCND2 variants of PLCB4: p.Arg621His (c.1862G>A; Gordon
et al., 2013b; Rieder et al., 2012), p.Tyr623Cys (c.1868A>G;
Rieder et al., 2012), pGlu358Val (c.1073A>T; Gordon et al.,
2013b; Shkalim et al., 2008) or p.Asp360Val (c.1079A>T; Gordon
et al., 2013b; Greig et al., 2012). When transfected into HEK293T
cells, confocal microscopy showed that the extent of membrane
fluorescence of the variants was similar to that of wild-type PLCB4
(Fig. 1D-H). Furthermore, quantitative analysis of western blots
from three different transfection experiments found no statistical
difference in the expression level of the constructs (Fig. 1I,J).
We next tested whether overexpression of a representative
PLCB4 variant, p.Arg621His, would interfere with endogenous
PLCB isoforms in HEK293T cells. PLCB activity was assessed
using time-lapse imaging and the fluorescent reporter GFP-C1A

Fig. 1. ARCND2-associated variants cause missense mutations in PLCB4
active site residues. (A) Protein domains of PLCB4. ARCND2 variants affect
residues in the X and Y domains that form the catalytic pocket. Residues
examined in this study are highlighted in red in A and C. (B,C) The active site in
the PLCB4 homology model, with yellow and orange structures representing
the X and Y domains, respectively. The calcium ion (Ca2+, purple) and IP3
molecule (green) are superimposed on the active site (B), and are surrounded
by residues affected by ARCND2 variants (in red in C). (D-H) Representative
immunofluorescence confocal microscopy images of HEK293T cells
transfected with Myc-FLAG-tagged wild-type PLCB4 or PLCB4 mutants and
visualized with an Alexa Fluor 488-labeled anti-Myc antibody. Scale bar:
20 µm. (I) Representative western blot showing relative expression levels of
Myc-FLAG-tagged wild-type PLCB4 or PLCB4 mutants transfected into
HEK293T cells. (J) Quantification of PLCB4 mutant expression in western blot
analysis, shown as fold difference relative to wild-type expression. Each data
point represents a biological replicate (n=3). Statistical significance versus wild
type was calculated using Prism and an unpaired two-tailed t-test
( p.Arg621His, P=0.56; p.Tyr623Cys, P=0.37; p.Glu358Val, P=0.53;
p.Asp360Val, P=0.34). CTD, C-terminal coiled-coil domain; EF (4X), four
tandem copies of the EF-Hand motif; IB, immunoblot; kDa, kilo Dalton; ns, not
significant. PH, pleckstrin homology domain.
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that translocates from the cytoplasm to plasma membrane upon
DAG production (Oancea et al., 1998) (Fig. 2A). Of the cells
transfected with wild-type PLCB4, in which EDN1 addition elicited
a translocation response, membrane fluorescence was observed
within the first imaging frame after EDN1 addition [30±0 s (s.e.m.)]
(Fig. 2B,C,G). Cells transfected with empty vector responded to
EDN1 similarly, likely due to endogenous PLCB (Fig. S1). In
contrast, in cells transfected with PLCB4 p.Arg621His, EDN1
addition elicited a significantly delayed translocation response,
with an average response time of 270±70 s (s.e.m.) (P<0.0001)
(Fig. 2D-G). We then quantified the difference in the translocation
response by calculating the relative increase in membrane
fluorescence (ΔFpm; see Materials and Methods) for individual
cells in each population, plotting the ΔFpm values in a histogram,
and fitting the data to a Gaussian curve. While the mean ΔFpm value
for wild-type PLCB4-expressing cells was 0.52±0.038 (s.e.m.)
(Fig. 2H, blue bars), the mean ΔFpm value for PLCB4 p.Arg621Hisexpressing cells was 0.053±0.015 (s.e.m.) (Fig. 2H, yellow bars),
with lower ΔFpm values indicating a weaker translocation response.
The difference in the distribution curve was statistically significant
(P<0.0001). Together, these results indicate that PLCB4 p.Arg621His
interferes with endogenous PLCB activity in a dominant-negative
manner, attenuating both the extent and latency of activation.

elicits a BRET signal by translocation-induced proximity of rLuc8C1A and Lyn-Venus (Fig. 3A). A previous study demonstrated that
a Fluorescence Resonance Energy Transfer-based version of this
assay accurately reports DAG production mediated by Gq-coupled
receptors (Falkenburger et al., 2013).
To verify the specificity of the BRET signal using this approach,
cells were co-transfected with rLuc8-C1A and Lyn-Venus along
with EDNRA or a loss-of-function EDNRA variant [EDNRA
p.Gln381Pro (c.1142A>C; Pritchard et al., 2020)]. Subsequent
EDN1 treatment produced a ΔBRET response from cells expressing
EDNRA but not from cells expressing EDNRA p.Gln381Pro
(Fig. 3B). Furthermore, pretreating cells with a Gq/11-specific small
molecule inhibitor YM-254890 (Nishimura et al., 2010; Taniguchi
et al., 2003) attenuated the ΔBRET response in a concentrationdependent manner (Fig. 3C). These data demonstrate that the
EDN1-stimulated ΔBRET response is mediated by the EDNRA-Gq/
11 signaling pathway.
Using this assay, we examined the functional impact of PLCB4
p.Arg621His on EDN1/EDNRA/Gq-mediated PLCB activity.
While EDN1 treatment of cells transfected with 500 ng of empty
vector or wild-type PLCB4 elicited similar maximum ΔBRET
responses of 0.041±0.0023 (s.e.m.) and 0.049±0.0014 (s.e.m.),
respectively (Fig. 3D-F), cells transfected with 500 ng of PLCB4
p.Arg621His elicited a relatively lower maximum ΔBRET response
of 0.022±0.0019 (s.e.m.) (Fig. 3D-F), indicating that PLCB4
p.Arg621His interferes with the activity of endogenous PLCB
isoforms. The maximum ΔBRET response was also attenuated in
cells co-transfected with a 1:1 [250 ng:250 ng, 0.031±0.0044
(s.e.m.)] or 9:1 [450 ng:50 ng, 0.029±0.0056 (s.e.m.)] ratio of
plasmid for wild-type PLCB4 and PLCB4 p.Arg621His, respectively
(Fig. 3D-F). These results illustrate that PLCB4 p.Arg621His
interferes with PLCB activity even when it is expressed at a substoichiometric level relative to wild-type PLCB4, exemplifying a
characteristic of a dominant-negative protein. We confirmed that

BRET analysis of PLCB4 variants supports a dominantnegative mechanism

To investigate the dominant-negative effect of ARCND2 variants
using a more quantitative approach, we designed a bystander
Bioluminescence Resonance Energy Transfer (BRET) assay
(Namkung et al., 2016) using the principle of the GFP-C1A
translocation assay. The PKCγ C1A domain (C1A) was tagged with
Renilla Luciferase 8 (rLuc8) to create a rLuc8-C1A BRET donor.
When used together with a plasma membrane-localized acceptor
protein, Lyn-Venus (Gulyás et al., 2017), the presence of DAG

Fig. 2. PLCB4 p.Arg621His attenuates EDNRA signaling.
(A) Schematic showing endothelin 1 (EDN1)/endothelin A
receptor (EDNRA) signaling triggering PLCB4-mediated PIP2
hydrolysis. This results in cytoplasm-to-plasma membrane
translocation of the DAG sensor GFP-C1A. (B-F)
Representative time-lapse images of the GFP translocation
assay in HEK293T cells transfected with GFP-C1A, EDNRA
and wild-type PLCB4 or PLCB4 p.Arg621His. Time relative to
EDN1 addition is noted. Scale bar: 20 µm. (G) Quantification of
the translocation response time observed in individual cells
(open circles), with only responding cells used for data analysis
(n=90 for wild-type PLCB4-tranfected cells and n=25 for PLCB4
p.Arg621His-transfected cells). Error bars represent s.e.m.
Statistical significance was calculated using Prism and an
unpaired two-tailed t-test (P<0001). ****P<0.0001.
(H) Quantification of the translocation response profiles for cell
populations expressing wild-type PLCB4 or PLCB4
p.Arg621His. The translocation response was quantified for
individual cells by measuring the relative increase in membrane
fluorescence, expressed as ΔFpm on the x-axis. The y-axis
represents the percentage of total cells that elicited the
indicated ΔFpm value. α, G protein α subunit q (Gαq); β, G
protein β subunit; DAG, diacylglycerol; γ, G protein γ subunit;
IP3, inositol triphosphate.
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Fig. 3. ARCND2-associated PLCB4 mutants exert dominant-negative interference of the EDNRA signaling pathway. (A) Schematic showing how BRET is
achieved in response to EDN1. Upon translocation-induced proximity, luminescence (460 nm) from the rLuc8-C1A BRET donor excites the Lyn-Venus BRET
acceptor, resulting in fluorescence emission (540 nm) (ΔBRET; see Materials and Methods). (B) ΔBRET response after EDN1 stimulation (arrow) in HEK293T
cells co-transfected with rLuc8-C1A, Lyn-Venus and wild-type EDNRA or a loss-of-function EDNRA mutant ( p.Gln381Pro). ΔBRET traces are an average of three
experiments. Shaded boxes represent s.e.m. (C) The Gq/11-specific inhibitor YM-254890 attenuates the EDN1-stimulated maximum ΔBRET response in cells
transfected with BRET sensor components and EDNRA. Each point represents an average of at least three experiments. (D) Representative western blots of cells
transfected with the indicated amount (nanograms; ng) of plasmid. (E) ΔBRET response after EDN1 stimulation (arrow) in cells co-transfected with BRET sensor
components, EDNRA and differing amounts of wild-type PLCB4 and PLCB4 p.Arg621His. ΔBRET traces are an average of three (0:0, 500:0 and 0:500), four
(450:50) or five (250:250) individual experiments. (F) Quantification of the maximum ΔBRET response in E. Data points are individual experiments with n values
listed in E. Error bars represent s.e.m. Statistical significance was calculated using Prism and an unpaired two-tailed t-test (mock transfection versus 500:0,
P=0.093; 500:0 versus 450:50, P=0.0372; 500:0 versus 250:250, P=0.037; 500:0 versus 0:500, P=0.0017). (G) ΔBRET response after EDN1 stimulation (arrow)
in cells co-transfected with BRET sensor components, EDNRA and wild-type PLCB4 or the indicated PLCB4 mutant. Traces are an average of three experiments,
except for p.Glu358Val (n=4). (H) Quantification of the maximum ΔBRET response in G. Data points are individual experiments with n values listed in G. Error bars
represent s.e.m. Statistical significance versus wild type was calculated using Prism and an unpaired two-tailed t-test ( p.Tyr623Cys, P=0.032; p.Glu358Val,
P=0.015; p.Asp360Val, P=0.0018). *P<0.05; **P<0.01. IB, immunoblot antibody; ns, not significant.

other ARCND2 variants, PLCB4 p.Tyr623Cys [0.031±0.0023
(s.e.m.)], PLCB4 p.Glu358Val [0.017±0.0047 (s.e.m.)] and PLCB4
p.Asp360Val [0.00.014±0.0019 (s.e.m.)], similarly behaved like
dominant-negative proteins. Cells transfected with plasmid (500 ng)
for any one of these variants resulted in an attenuated ΔBRET
response (Fig. 3G,H).

The dominant-negative effect of PLCB4 p.Arg621His is
abolished by blocking Gq/11-mediated activation

PLCB isoforms are activated by Gq/11 through a critical Gq/11PLCB binding interface that is facilitated by a conserved Hα1/Hα2
helix-turn-helix motif on the C2 domain C terminus in PLCB
isoforms (Waldo et al., 2010) (Fig. 4A). This region of PLCB
4
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Fig. 4. The dominant-negative action of PLCB4 p.Arg621His is alleviated by disrupting the Gq-PLCB4 interaction interface. (A) Homology model of
PLCB4 (gray and purple ribbons) shown interacting with a GTP-bound Gαq crystal structure (green) and containing a calcium ion (Ca2+, purple). The
Hα1/Hα2 helix-turn-helix motif on the C2 domain C terminus ( purple) of PLCB4 binds to a shallow cavity in Gαq. (B) Sequence alignment of the Hα1 and Hα2
helix-turn-helix motif for human PLCB isoforms and PLCB4 from different species isoforms that are required for Gq-mediated activation (Waldo et al., 2010). Red
boxes with white characters represent highly conserved residues; red characters represent residues with equivalent physicochemical properties; blue frames
highlight highly conserved regions. The conserved proline at position 838 was mutagenized in this study to an alanine ( p.Pro838Ala in PLCB4) and is denoted in
yellow above the sequence by an ‘A’. (C,D) Representative immunofluorescence confocal microscopy images of cells transfected with indicated PLCB4 mutants
and visualized with an Alexa Fluor 488-labeled anti-Myc antibody. Scale bar: 20 µm. (E) Representative western blot showing expression levels of wild-type
PLCB4 and PLCB4 mutants transfected in HEK293T cells. (F) Quantification of PLCB4 variant expression in western blot analysis, expressed as fold difference
relative to wild-type expression (n=4). Each data point represents a biological replicate. Statistical significance versus wild type was calculated using Prism and an
unpaired two-tailed t-test ( p.Pro838Ala, P=0.88; p.Arg621His, P=0.61; p.Arg621His;p.Pro838Ala, P=0.37). (G) EDN1-stimulated (arrow) ΔBRET response in
cells co-transfected with BRET sensor components, EDNRA and wild-type PLCB4 or indicated PLCB4 mutants. Traces are an average of at least three
experiments (n=3 for wild type and p.Arg621His, n=4 for p.Arg621His;p.Pro838Ala and n=5 for p.Pro838Ala). (H) Quantification of maximum ΔBRET response in
G. Each data point represents a biological replicate with n values given in G. Error bars represent s.e.m. Statistical significance was calculated using Prism and an
unpaired two-tailed t-test for the following comparisons. Wild type versus: p.Pro838Ala, P=0.35; p.Arg621His, P=0.0096; p.Arg621His;p.Pro838Ala, P=0.13.
p.Pro838Ala versus: p.Arg621His, P=0.027; p.Arg621His;p.Pro838Ala, P=0.76. p.Arg621His versus p.Arg621His;p.Pro838Ala, P=0.0012. *P<0.05, **P<0.01;
ns, not significant.
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isoforms is highly conserved among a wide variety of vertebrates,
including Sceloporus undulatus (the Eastern fence lizard) (Fig. 4B).
In principle, blocking the activation mechanism of a PLCB4 mutant
would diminish its dominant-negative effect. We tested this by
introducing a point mutation, p.Pro838Ala (c.2512C>G), which
should disrupt a conserved PLCB-Gq/11-binding interface that is
required for PIP2 hydrolysis (Waldo et al., 2010), to wild-type
PLCB4 and in cis with PLCB4 p.Arg621His (Fig. 4B). After
transfecting the two variants, confocal microscopy showed that
the extent of membrane fluorescence of PLCB4 p.Pro838Ala
(Fig. 4C) and PLCB4 p.Arg621His;p.Pro838Ala (Fig. 4D) was
similar. Furthermore, quantitative analysis of western blots from
four different transfection experiments found no statistical
difference in the expression of the two constructs compared with
wild-type PLCB4 and PLCB4 p.Arg621His (Fig. 4E,F). In our
BRET assay, although the maximum ΔBRET response after EDN1
addition was slightly lower in cells expressing PLCB4 p.Pro838Ala
[(0.038±0.0040 (s.e.m.)] compared with wild-type PLCB4
[(0.047±0.0043 (s.e.m.)], the difference was not statistically
significant (Fig. 4G,H). In contrast, the maximum ΔBRET
response was approximately twofold greater in cells expressing
PLCB4 p.Arg621His;p.Pro838Ala [(0.036±0.0016 (s.e.m.)] compared
with cells expressing PLCB4 p.Arg621His. [0.018±0.00089
(s.e.m.)] (Fig. 4G,H), indicating that the p.Pro838Ala mutation
diminished the dominant-negative effect of PLCB4 p.Arg621His.
The difference between wild-type PLCB4 and PLCB4
p.Arg621His;p.Pro838Ala was not statistically significant. These
results illustrate that the dominant-negative effect of PLCB4
mutants is dependent on Gq/11-mediated activation.

significant lower jaw defects (Parada et al., 2015), further
highlighting the significance of this pathway. To determine
whether dominant-negative PLCB4 variants disrupt the MEK/
ERK pathway, we used a serum response element (SRE)-controlled
transcriptional reporter, SRE:luc2p, that expresses luciferase upon
activation of the MEK/ERK pathway (Cheng et al., 2010) (Fig. 5A).
HEK293 cells were co-transfected with a constitutively active Gq
mutant Gq p.Gln209Leu (c.626A>T) (Kalinec et al., 1992), which
stimulates SRE activity via the MEK/ERK pathway in a receptorindependent manner, and either wild-type PLCB4 or PLCB4
mutants. SRE activity was reduced in PLCB4 mutant-expressing
cells compared with wild-type PLCB4-expressing cells, with a
reduction in SRE activity of 37.6% (PLCB4 p.Arg621His), 63.4%
(PLCB4 p.Tyr623Cys), 50.1% (PLCB4 p.Glu358Val) and 36.2%
(PLCB4 p.Asp360Val) (Fig. 5B). The difference in SRE activity
was not statistically significant between cells expressing wild-type
PLCB4 and PLCB4 p.Arg621His;p.Pro838Ala compound mutant
(Fig. 5B). These findings illustrate that dominant-negative
interference of the initial secondary messenger response (IP3 and
DAG production) by PLCB4 mutants leads to the abatement of
downstream signaling and gene expression events.

The production of DAG by the EDNRA-Gq/11-PLCB signaling
pathway subsequently activates the MEK/ERK pathway (Cai et al.,
1997; Janknecht et al., 1993) (Fig. 5A), which is involved in lower
jaw development. E18.5 Erk2fl/fl;Wnt1-Cre embryos have

Fig. 5. ARCND2-associated PLCB4 mutants interfere with SRE activity in
a dominant-negative manner. (A) Schematic of the signaling pathway that
stimulates SRE:luc2p transcription. Gq p.Gln209Leu activates the Raf-MEK/
ERK pathway through PLCB, resulting in activation of the serum response
element (SRE). (B) Relative luminescence from cells co-transfected with SRE:
luc2p, Gq p.Gln209Leu and wild-type or mutant PLCB4. Luminescence is
expressed as the fold change relative to cells expressing wild-type PLCB4.
Data points are individual experiments [n=3 for all samples except wild type
and p.Arg621His (n=4)]. Error bars represent s.e.m. Significance versus wild
type was calculated using Prism and an unpaired two-tailed t-test
( p.Arg621His, P<0.0001; p.Tyr623Cys, P=0.0008; p.Glu358Val, P=0.0002;
p.Asp360Val, P<0.0001; p.Pro838Ala;p.Arg621His, P=0.36). ***P<0.001,
****P<0.0001; ns, not significant.

We next examined whether an ARCND2-associated variant is
sufficient to recapitulate the ARCND phenotype in mice. To do this,
CRISPR/Cas9 and homology-directed repair (HDR) was used to
generate knock-in ‘founder’ (F0) perinatal embryos harboring the
orthologous variant (c.1862G>A; p.Arg621His) in Plcb4. Of the 69
embryos harvested at E18.5, we identified three embryos harboring
at least one knock-in allele; one was homozygous for the knock-in
allele (Plcb4KI/KI) and the other two were compound heterozygotes
harboring the knock-in allele and an insertion/deletion (indel)
allele generated by non-homologous end joining (NHEJ)
(Plcb4Indel/KI). Five other embryos were heterozygous for an indel
allele (Plcb4wt/Indel ). Embryos harboring at least one knock-in allele
(n=3) or only indel alleles (n=5) were scanned using microcomputed tomography (µCT), and embryos harboring a knock-in
allele were subsequently processed for bone and cartilage staining
with Alizarin Red and Alcian Blue.
All F0 embryos harboring at least one knock-in (KI) allele
(Plcb4KI/KI and Plcb4Indel/KI) had several defects in head skeletal
structures previously observed in hypomorphic Ednra mouse
models (Clouthier et al., 2003; Ruest and Clouthier, 2009;
Tavares et al., 2012). Compared with control (Plcb4wt/wt) embryos
(Fig. 6A,D; n=3), the proximal mandible of Plcb4Indel/KI and
Plcb4KI/KI embryos was disorganized, with absent or hypoplastic
mandibular processes (Fig. 6B,C,E,F). This included reduction in
the size of the condylar process and reduction or loss of the coronoid
and angular processes (Fig. 6E,F). In addition, a small bone was
attached to the proximal mandible by a fibrous suture that we have
previously identified as a duplication of the jugal bone of the
zygomatic arch that occurs in hypomorphic Ednra mouse models
(Clouthier et al., 2003; Ruest and Clouthier, 2009; Tavares et al.,
2012). µCT scans performed before bone and cartilage staining
provided additional resolution of these changes, including dysplasia
or absence of the coronoid and angular processes in Plcb4KI/KI
embryos (Fig. 6H,I,K,L) compared with a control embryo
(Fig. 6G,J). No overt changes in skull structure were observed by
µCT in embryos harboring only indels (Plcb4wt/Indel, n=5) (data not
shown) or in embryos with unmodified alleles (n=3) (data not
shown). The normal craniofacial phenotype of Plcb4wt/Indel embryos
6
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An ARCND2-associated PLCB4 mutation recapitulates
hypomorphic Ednra phenotypes in mice

Fig. 6. F0 CRISPR mouse model of ARCND. (A-O) Skulls from E18.5
embryos following Alizarin Red and Alcian Blue staining (A-F,M-O) or µCT
scanning (G-L) of wild-type Plcb4 (A,D,G,J,M), Plcb4Indel/KI (B,E,H,K,N) and
Plcb4KI/KI (C,F,I,L,O) embryos. Black arrows in N and O indicate the presence
of an ectopic osseous strut (eos). ap, angular process; bo, basioccipital bone;
bs, basisphenoid bone; cdp, condylar process; cop, coronoid process; in,
incisor; j, jugal; j*, duplicated jugal; lo, lamina obturans; lo*, duplicated lamina
obturans; md, mandible; pl, palatine; pt, pterygoid; sq, squamosal; ty, tympanic
ring bone.

is consistent with Plcb4+/− and Plcb4−/− mice, which have no
reported changes in skull structures (Jiang et al., 1996). These
results indicate that a single Plcb4KI allele is sufficient to cause
craniofacial defects.
In addition to the duplicated jugal bone, we observed an
additional defect in the posterior roof of the oral cavity is often
associated with reduced (though not absent) EDNRA signaling
(Clouthier et al., 2003; Ruest and Clouthier, 2009). Ectopic osseus
struts of variable size and shape extended mediolaterally from the
lateral pterygoid bones (Fig. 6K,L,N,O) to middle ear structures.
The bone struts were larger in the Plcb4KI/KI embryo compared with
the Plcb4Indel/KI embryo (Fig. 6N,O), although embryo to embryo
variation in the size of these struts has been previously observed
(Clouthier et al., 2003; Ruest and Clouthier, 2009). When only
partially present, the strut was seen as a bony nodule lying in
between the pterygoid and the middle ear (Clouthier et al., 2003;
Ruest and Clouthier, 2009) (Fig. 6N).
To better visualize changes in the posterior oral cavity, control
and Plcb4KI/KI embryos were scanned at high resolution by µCT
after bone staining and removal of the mandible. Compared
with control embryos (Fig. 7A,C), the lamina obturans (the
intramembranous bone region of the alisphenoid) in Plcb4KI/KI
embryos was partially duplicated (Fig. 7B,D), a finding previously
observed in Ednra−/− embryos (Ruest et al., 2004). More striking
was that the ectopic osseous struts in Plcb4KI/KI embryos had a
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Fig. 7. Ectopic bone formation in the posterior palate of CRISPR embryos.
(A-H) µCT analysis of the skull in E18.5 control (A,C,E,G) and Plcb4KI/KI (B,D,F,
H) embryos. (A-D) Ventral (A,B) and frontal (C,D) views of embryos. Purple
dashed lines indicate the fusion point of the lateral pterygoid (lpt) and the
ectopic osseous strut (eos). White arrows in D indicate tooth-like projections (t)
on the ectopic osseous strut. (E-H) Isolated ventral (E,F) and frontal (G,H)
views of the digitally isolated basisphenoid (bs)/pterygoid bone complex. The
medial pterygoid (mpt) is pseudo-colored purple, the lateral pterygoid is
pseudo-colored pink, the ectopic osseous strut is pseudo-colored green and
the tooth-like structures are pseudo-colored orange. bo, basioccipital bone; hy,
hyoid; in, incisor; lo, lamina obturans; lo*,duplicated lamina obturans; mx,
maxilla; pl, palatine; pmx, premaxilla bone; ty, tympanic ring bone.

distinct shape with similar features on either side of the skull
(Fig. 7B,D,F,H; Movies 1 and 2), resembling posterior or quadrate
processes of the pterygoid generally observed in the skull of many
non-mammalian amniotes (Evans, 2008; Romer, 1956). Both struts
were fused to the ventral surface of the lateral pterygoid wings,
which themselves were displaced proximally on the basisphenoid
(Fig. 7B,F,H) compared with control embryos (Fig. 7A,E,G). The
medial pterygoids were also dysplastic (Fig. 7B,F,H) compared with
control embryos (Fig. 7A,E,G). The osseous struts were flattened on
their ventral surface and were beveled on the medial end closest to
the pterygoid bone (Fig. 7D,F; Movies 1 and 2). Furthermore,
prominent rounded bony projections emanated from the bone and
extended ventrally (Fig. 7D,H), resembling pterygoid teeth variably
observed in non-mammalian amniotes (Evans, 2008; Mahler and
Kearney, 2006; Romer, 1956). These observations suggest that the
ectopic osseous struts do not simply represent random ossification
of mesenchyme but rather an atavistic change in this region that
results in the formation of structures that have been lost in the class
Mammalia (Hall, 1984; Smith and Schneider, 1998).
Novel phenotype in a child with ARCND2

The role for EDNRA signaling in jaw development is highly
conserved in jawed vertebrates (Clouthier et al., 2013). To examine
whether the skull changes observed in Plcb4 CRISPR mouse
embryos are also present in individuals with ARCND2, we analyzed
7
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3D computed tomography (CT) scan data from a child with
ARCND2 (age 11 months) carrying the PLCB4 p.Tyr623Cys
variant (Rieder et al., 2012). Compared with a similarly aged
unaffected child (Fig. 8A,C), the child with ARCND2 had a
mandible that more closely resembled a mirror-image duplication
of the maxilla, had no coronoid process and had a dysplastic
pseudo-condylar process (Fig. 8B,D; Rieder et al., 2012), similar to
duplications observed in mouse embryos that lack EDNRA
signaling (Clouthier et al., 1998; Kurihara et al., 1994; Ozeki
et al., 2004; Ruest et al., 2004; Yanagisawa et al., 1998).
Furthermore, an anomalous laterally displaced bone is attached to

the duplicated maxilla and extends proximally (outlined in magenta
in Fig. 8B,D). This bone resembles the zygoma/jugal bone (outlined
in aqua) in both control (Fig. 8A,C) and ARCND2 (Fig. 8B,D)
individuals, suggesting that it represents a duplicated zygoma. This
duplicated zygoma bone is fused to the duplicated maxilla through
what we interpret as a duplication of the zygomaticomaxillary suture
(Fig. 8B, similar to the fibrous suture observed in Plcb4 CRISPR
embryos; Fig. 6E,F).
We also carefully inspected the skull base in the child with
ARCND2 at a location analogous to that where the ectopic osseous
strut was observed in Plcb4 CRISPR embryos (Fig. 6N,O,
Fig. 7B,D,F,H). In a 3D CT scan from an unaffected similarly
aged child, the lateral and medial pterygoid plates are well defined,
with the foramen ovale clearly apparent (black arrow in Fig. 8E). In
contrast, the pterygoid plates in the child with ARCND2 are mildly
dysplastic (Fig. 8F) and a pterygospinous bar (Henry et al., 2020)
bridges the foramen ovale (black arrow in Fig. 8F) before continuing
towards and fusing with the spinous region of the sphenoid bone
(Fig. 8F). When the child was older, this osseous bar enlarged and
appeared distinct from the pterygospinous bar described as a human
anatomical variant (not shown). In addition, an abnormal osseous
process arises from the tympanic region of the temporal bone. This
process contains abnormal bony projections pointed towards the
dysplastic mandibular fossa bilaterally and towards the duplicated
maxilla (yellow arrows in Fig. 8F,H). Although these findings do
not completely phenocopy the ectopic osseous struts in
hypomorphic Ednra mouse models or Plcb4 CRISPR mouse
embryos, it is reasonable to assume that this structure represents a
phenotypic spectrum of an ectopic atavistic change that affects the
region of the posterior roof of the oral cavity and/or skull base region
that occurs when EDNRA signaling is reduced.
DISCUSSION

The dominant-negative mechanism of PLCB4 variants
Fig. 8. Similar morphological changes observed in CRISPR embryos
exist in the skull of a child with ARCND2. (A-F) Three-dimensional
renderings of CT scans from control (A,C,E,G) and a child with ARCND2
(B,D,F,H). (A-D) Frontal (A,B) and frontal oblique (C,D) views of the skull. The
difference between A,B and C,D is 30° of head rotation. Cyan outlines in
A-D indicate the zygoma (zy). Magenta outlines in B and D indicate the
duplicated zygoma (zy*). (E-H) Inferior oblique (E,F) and inferior surface
(G,H) views. The difference between E,F and G,H is 30° of head pitch.
The black arrow in E indicates the foramen ovale. Yellow arrows in F and H
indicate the dysplastic osseous projections that extend from the tympanic
portion of the temporal bone (tt). The black arrow in F indicates a
pterygospinous bar. bs, basisphenoid bone; cd, condylar process; co,
coronoid process; lpt, lateral pterygoid; md, mandible; mpt, medial pterygoid;
mx, maxilla; mx*, duplicated maxilla; pcd, pseudo-condylar process; ptm,
petrous portion of temporal bone; sps, spinous process of the sphenoid bone;
zp, zygomatic process of the temporal bone; zym, zygomaticomaxillary suture;
zym*, duplicated zygomaticomaxillary suture.

ARCND2 PLCB4 variants affect amino acids that are essential for
the PIP2 hydrolysis reaction mechanism (Ellis et al., 1998; Gresset
et al., 2012), although why these mutations confer a dominantnegative effect rather than loss of function remains unclear. One
explanation is that PLCB4 mutants trap PIP2 in a nonproductive
enzyme-substrate complex. Given the low abundance of PIP2 in
cells, accounting for only ∼1% of total membrane phospholipids
(Czech, 2000; Harraz et al., 2020), PLCB4 mutants would sequester
the available pool of PIP2 from wild-type PLCB isoforms, resulting
in the diminished output of IP3 and DAG. This dominant-negative
interference could be further exacerbated if the disease variants also
impair the GTPase-activating protein (GAP) activity in addition to
PIP2 hydrolysis activity of PLCB4. The GAP activity of PLCB
accelerates the GTP hydrolysis rate of GTP-bound Gq/11, which
facilitates rapid dissociation of Gq/11 from PLCB and subsequent
8
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sufficient to cause jaw defects and changes in the posterior roof of
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reactivation of Gq/11 by a ligand-bound receptor. This on-off
cycling mechanism, termed ‘kinetic scaffolding’ (Ross, 2011;
Waldo et al., 2010), allows for rapid, repeated activation of PLCB to
produce a temporally focused, high-amplitude signaling response.
Thus, impaired GAP activity could potentially prolong the Gq/11PLCB4 interaction and deplete the pool of Gq/11 that is available
for both ligand-bound EDNRA and wild-type PLCB isoforms.
Additional experiments are needed to determine whether these
disease variants affect GAP activity and/or dissociation kinetics of
the Gq/11-PLCB4 complex.
ARCND2 disease variants may also disrupt signaling dynamics
controlled by preassembled GPCR-G protein-effector complexes.
G proteins, including Gq, can exist as preassembled protein
complexes with GPCRs, in which the receptor, G proteins and
effectors exist in very close proximity to each other in the absence of
ligand (Qin et al., 2011). This close proximity leads to the presence
of ‘high-affinity’ receptors (Civciristov et al., 2018), in which the
presence of a ligand leads to a rapid increase in signaling due to
mechanisms that may include rebinding of ligand, increased ligand
binding time and increased ligand sequestration/concentration
(Dityatev and Schachner, 2006; Herbette et al., 1988; Hrabětová
and Nicholson, 2004; Kane et al., 2008; Sargent et al., 1988; Sykes
et al., 2014; Vargová and Syková, 2008; Vauquelin and Charlton,
2010). These high-affinity receptors can also respond to ultra-low
ligand concentrations (Civciristov et al., 2018). The remaining
receptors that are not part of a preassembled complex are considered
low-affinity receptors and respond to high ligand concentrations
(Civciristov et al., 2018). EDNRA has not been demonstrated to
exist as part of a preassembled protein complex (Civciristov and
Halls, 2019). However, if such preassembly occurred, it is possible
that at least some EDNRAs could be stabilized in a preassembly
complex containing dominant-negative PLCB4 (Staus et al., 2016).
While these high-affinity receptors would not be able generate
DAG, low-affinity receptors might still be able to generate DAG if
the signaling complex used endogenous PLCB, potentially
accounting for why we observe only partial dominant-negative
signaling in our assays. In addition, signaling through these lowaffinity receptors might explain why translocation of fluorescent
DAG reporter to the membrane is so much slower in cells expressing
PLCB4 variants (Fig. 2). Testing this possibility will require
concentration-response and gene expression studies with ligand
concentrations far below those used in this study.
The fact that DAG and IP3 could be generated in these models
could explain why individuals with ARNCD develop defects in
craniofacial elements but not in the cardiovascular outflow tract.
Targeted deletion of Ednra in mice is neonatal lethal, with defects in
both craniofacial and cardiovascular structures resulting from
aberrant cranial and cardiac neural crest cell patterning,
respectively. However, based on analysis of Ednra+/+↔Ednra−/−
chimeric embryos (Clouthier et al., 2003), it appears that
cardiovascular patterning requires only between 10 and 15% of
normal EDNRA signaling, whereas craniofacial patterning requires
50% of normal signaling. Thus, although PLCB4 mutations reduce
the overall activity and activation kinetics of other PLCB isoforms,
the extent and rate of PIP2 conversion to DAG and IP3 is likely
sufficient for normal cardiovascular development.
It is also possible that ARCND2 disease variants impact
processes beyond craniofacial development, as PLCB4 can be
activated by a multitude of GPCRs besides EDNRA through
various mechanisms. PLCB4 is predominantly expressed in the
brain and retina, with lower expression in tissues and organs that
also express Gq/11 (Uhlén et al., 2015; Wettschureck and

Offermanns, 2005). Plcb4−/− mice have visual impairments and
nerve defects (Han and Simon, 2011; Jiang et al., 1996), suggesting
that PLCB4 dominant-negative variants have the potential to impact
a wider range of processes than currently known. In addition, G15
and G16, which belong to the Gq/11 family, can couple
promiscuously to a wide variety of GPCRs, and therefore can
theoretically link Gs-, Gi/o- and G12/13-coupled receptors to PLCB
activity (Offermanns and Simon, 1995). This could, in turn, expand
functional consequences of ARCND2 variants to a group of cell
types and tissues expressing G15 and G16 (Wilkie et al., 1991). Free
Gβγ subunits from Gi/o-coupled receptors can also stimulate PLCB
activity (Smrcka, 2008), although our assays did not test whether the
ARCND2 variants could also interfere with Gβγ-mediated
phospholipase activity. The functional consequence of ARCND2
variants may be negligible, however, because PLCB4 exhibits the
lowest sensitivity to Gβγ relative to other PLCB isoforms (Lee et al.,
1994). Although defects beyond craniofacial anomalies have not
been reported in individuals with ARCND2, behavioral and
phenotypic analysis of stable Plcb4R621H mice may reveal
additional deficits caused by ARCND2 disease variants, allowing
a better understanding of whether other receptor systems and
signaling pathways are affected.

Although the human ARCND phenotype is highly variable
(Gordon et al., 2013a,b; Nabil et al., 2020; Rieder et al., 2012),
one stereotypical change is the apparent homeotic transformation of
the mandible to maxilla-like structures (Clouthier et al., 2013;
Gordon et al., 2014; Rieder et al., 2012). Analysis of our Plcb4
CRISPR embryos has informed our investigation of CT scans from
a child with ARCND2 to better define and understand the changes
in facial structures. This has included identifying the abnormal
lateral eminence on the pseudo-maxilla as a duplicated zygoma
( jugal) bone, complete with a duplicated zygomaticomaxillary
suture. This duplicated zygoma is the second homeotic
transformation identified to date in individuals with ARCND2
and illustrates the highly conserved role of EDNRA signaling in
establishing the identity of NCCs that give rise to lower jaw
structures. Although the actual signaling disruptions leading to
changes in proximal jaw development, including transformations,
are not clear, it is interesting that proximal mandible defects in
E18.5 Erk2fl/fl;Wnt1-Cre embryos (Parada et al., 2015) resemble
those in E18.5 Gnaqfl/fl;Gna11−/−;P0-Cre embryos (DettlaffSwiercz et al., 2005). Examining the gene regulatory networks
regulated by the Gq/ERK pathway in stable mouse lines carrying the
PLCB4 p.Arg621His variant will be useful in dissecting these
phenotypes further.
EDNRA signaling and evolution of the posterior oral cavity

The ectopic osseous struts that extend from the pterygoid in our
Plcb4 CRISPR mouse embryos were also observed in Ednra+/
+↔Ednra−/− chimeric mouse embryos and in Ednrafl/fl;Wnt1-Cre
embryos, but not in Ednra−/− embryos (Clouthier et al., 1998, 2003;
Ruest and Clouthier, 2009). This suggests that these structures form
in animal models and in humans under conditions where EDNRA
signaling is reduced but not absent. Our µCT scans have now shown
that this strut has a highly organized structure that resembles the
pterygoid (quadrate) processes of some extinct and extant amniotes,
and also bears tooth-like structures. Generally, in non-mammalian
amniotes, the pterygoid is characterized as a large triradiate structure
that includes the posterior region of the palate and is one of the
9
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largest intramembranous bones of the skull. The posterolateral
projections are the posterior or quadrate processes that typically
contact (or nearly so) the median lamina of the quadrate (Romer,
1956; Versluys, 1936). In birds, the pterygoid is essentially
composed of only these posterolateral projections (Marinelli,
1936). Similarly, the osseous projections observed in Plcb4KI/KI
embryos also appear to articulate with the incus (Fig. 6O) (the
mammalian equivalent of the quadrate). The posterior processes of
the pterygoid are also present in synapsid lineages, including the
precursors of mammals. Although they became gradually reduced
among many cynodonts (Parrington and Westoll, 1940), they were
retained in the Lower Jurassic mammaliaform Morganucodon
(Kermack et al., 1981). Our results suggest that the developmental
program for a more generalized non-mammalian palate remains
‘available’ at some level in mammals (Hall, 1984; Smith and
Schneider, 1998) and it can be reactivated when EDNRA signaling
drops below a certain threshold. Endothelin signaling long preceded
the evolution of the jaw and was actually crucial for the evolution of
the entire neural crest population (Square et al., 2020). Subsequent
incorporation of new downstream targets of Ednra, like Hand genes,
likely facilitated jaw evolution. Based on our results here, it is
reasonable to suggest that the evolution of the Mammalia lower
facial complex may have been mediated not only by the presence of
EDNRA signaling in NCCs, but by increasing levels of EDNRA
signaling in NCCs. This likely led to advantageous changes in lower
jaw and middle ear structures (including the separation of the middle
ear ossicles from the posterior palate/posterior oral cavity), with one
consequence being repression of the posterior pterygoid processes.
Another puzzling question is the identity of the tooth-like
projections on the posterior processes in Plcb4 CRISPR mice and in
a child with ARCND. Palatal dentition is common across a diverse
array of non-mammalian amniotes (Romer, 1956). In squamate
reptiles, these teeth are most often found on the pterygoid, though
are variably present (Skawiński and Borczyk, 2017), largely on a
lineage-specific basis (Mahler and Kearney, 2006). When present,
they do not develop fully until after birth/hatching (Barahona and
Barbadillo, 1997, 1998; Barahona et al., 1997), typically forming on
the anterior and/or central regions of the pterygoid, although they
can form as far posteriorly as the quadrate in some snakes. Their
function is poorly understood, although in snakes with highly
kinetic skulls, they participate in the specialized prey transport
mechanism that facilitates the ingestion of large prey items (Cundall
and Greene, 2000). In herbivorous iguanians, however, they have
been ascribed roles in the processing of plant material (Montanucci,
1968). Similar to the posterior pterygoid processes, in Plcb4
CRISPR embryos, these rounded projections likely represent a
spectrum of palatal dentition that has become reactivated due to
reduced EDNRA signaling. More-detailed analysis of these
structures may help further elucidate their actual identity and
developmental origin.
It is also interesting to consider how and when the struts and bony
projections arise during NCC development. As described above, we
believe that the struts and associated bony projections represent a
developmental continuum that results from reduced EDNRA
signaling within NCCs. From previous studies, we know that
EDNRA signaling is required between E8.0 and E9.5 to pattern
cranial NCCs in the mandibular region of arch one and more caudal
arches (Ruest and Clouthier, 2009). Furthermore, only a reduction
in EDNRA signaling during this time period results in strut
formation (Ruest and Clouthier, 2009). This reduced signaling
likely alters gene regulatory networks, permitting some NCCs to
adopt an alternative developmental trajectory in the middle ear/

posterior palate-oral cavity region and thus establishing a modified
framework for NCC-derived membranous bone formation.
Although the bones are ectopic (the strut and projections are not
normally seen in mice), they are normally shaped (they resembles
posterior pterygoid processes and pterygoid teeth). Subsequent
membranous ossification of these processes and projections, like
ossification of other facial structures in Ednra−/− embryos, does not
require EDNRA signaling (Clouthier et al., 1998; Ruest et al.,
2004). It will be interesting to compare NCC gene expression
between wild-type and Plcb4R621H mouse embryos to see whether
the basis of these atavistic changes can be uncovered. Taken
together, these findings illustrate that while evolution of the
craniofacial region is complex at both cellular and molecular
levels, differences in bone structure between species may require
only minor changes in common signaling networks, similar to how
differences in BMP4 levels shape the beak of Darwin’s finches
(Abzhanov et al., 2004) or how a ROR2 coding variant affects
pigeon beak shape (Boer et al., 2021).
MATERIALS AND METHODS
Homology modeling

All computation-based modeling was performed using Biovia Discovery
Studio 2020 (version 2.5, BIOVIA, Dassault Systèmes). Homology models
were generated for human PLCB4 using NP_000924.3 as the target
sequence for human PLCB4, and the structures for human PLCB2 (PDB:
2ZKM) (Hicks et al., 2008) or activated mouse Gq bound to human PLCB3
(PDB: 3OHM) (Waldo et al., 2010) as templates. Manual sequence
alignment was performed, and the homology models were subsequently
generated and further refined by energy minimization. The residues in the
models were corrected for physiological pH, and loop refinement was
performed. The most energy-favored model was retained for further
consideration. The model was refined further using CHARMM (Brooks
et al., 2009) and subjected to energy minimization (conjugate gradient, 1000
iterations) at a convergence of 0.001 kcal/mol using a Generalized Born
implicit solvent model (Feig and Brooks, 2004). In the initial minimization,
the protein backbone atoms were fixed, followed by a final minimization
where all atoms were unfixed and restraints were removed.
Sequence alignment

Amino acid sequence alignments were performed using Clustal Omega
(Madeira et al., 2019) and the following sequences: human PLCB4
(NP_000924.3), human PLCB1 (NP_056007.1), human PLCB2
(NP_004564.2), human PLCB3 (NP_000923.1) and Zebrafish PLCB3
(ABM91767.1). Figures were then generated using ESPript 3.0 (Robert and
Gouet, 2014).

All site-directed mutagenesis was performed using the QuickChange
Lightning Site-Directed Mutagenesis Kit (Agilent Technologies). The
human PLCB4 (NM_182797) expression construct pCMV6-Myc-DDKPLCB4 (Myc-FLAG-PLCB4) was purchased from Origene (RC217903).
The disease variants were introduced into Myc-FLAG-PLCB4 by sitedirected mutagenesis using the following primers for the indicated variant:
p.Arg621His, 5′ CAAACGGCAAATGAGTCACATTTACCCCAAGGGAG 3′ and 5′ CTCCCTTGGGGTAAATGTGACTCATTTGCCGTTTG 3′;
p.Tyr623Cys, 5′ CAAATGAGTCGCATTTGCCCCAAGGGAGGCCG 3′
and
5′
CGGCCTCCCTTGGGGCAAATGCGACTCATTTG
3′;
p.Glu358Val, 5′ GTTGCAGATGTGTTGTACTTGACTGCTGGG 3′ and
5′ CCCAGCAGTCAAGTACAACACATCTGCAAC 3′; p.Asp360Val,
5′ CAGATGTGTTGAACTTGTCTGCTGGGATGGAAAAG 3′ and 5′ CTTTTCCATCCCAGCAGACAAGTTCAACACATCTG 3′; p. Pro838Ala,
5′ CGTGGATGCTTTATCAGATGCAAAGAAATTTCTCTC 3′ and
5′ GAGAGAAATTTCTTTGCATCTGATAAAGCATCCACG 3′.
The human EDNRA expression construct pCMV6-XL5-EDNRA was
purchased from Origene (SC118901). The EDNRA p.Gln381Pro variant was
previously generated (Pritchard et al., 2020). pEYFP-N1-Lyn1-14-Venus
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(hereafter referred to as Lyn-Venus) was a gift from Péter Várnai (Gulyás
et al., 2017). pGL4.33 [luc2P/SRE/Hygro] (referred to as SRE:luc2P) was
purchased from Promega (E1340). pcDNA3.1-HA-Gq was a gift from
Nevin Lambert (Medical College of Georgia, University of Augusta). The
pcDNA3.1-HA-Gq p.Glu209Leu mutant was generated by site-directed
mutagenesis using the primers: 5′ GATGTAGGGGGCCTAAGGTCAGAGAG 3′ and 5′ CTCTCTGACCTTAGGCCCCCTACATC 3′.
pGFP-C1-PKCγ-C1A (referred to as GFP-C1A) was a gift from Tobias
Meyer (Addgene 21205). To replace GFP with rLuc8, the GFP-C1-PKCγC1A fragment was first PCR amplified with ClaI and XbaI restriction sites
on the 5′ and 3′ ends, respectively, using primers 5′ CCCATCGATATGGTGAGCAAGGGCGAGG 3′ and 5′ CTAGTCTAGATTACTTGTACAGCTCGTCCATGCCG 3′. The resulting amplicon was then cloned into a
pCS2 vector linearized with ClaI and XbaI using T4 DNA Ligase (New
England Biolabs). The resulting plasmid, pCS2-GFP-C1-PKCγ-C1A was
then digested with ClaI and EcoRI to excise the GFP fragment, resulting in a
linearized pCS2 acceptor plasmid containing PKCγ-C1A. Renilla luciferase
8 was PCR amplified from pEDNRA-rLuc8 (Pritchard et al., 2020) with
primers 5′ GCAGGATCCCATCGATATGGCTTCCAAGGTGTACGACC 3′ and 5′ GTCGACTGCAGAATTCCTGCTCGTTCTTCAGCACGC
3′, and then cloned in-frame on the 5′ end of PKCγ-C1A using the In-Fusion
Cloning Kit (Takara Bio), resulting in the plasmid pCS2-rLuc8-PKCγ-C1A
(hereafter referred to as rLuc8-C1A).

glucose, Millipore Sigma). Treatment with the Gq/11 inhibitor YM-254890
(Cayman Chemical) was performed by resuspending cells in reaction buffer
containing the indicated concentration of YM-254890 and incubating for
5 min before proceeding to the next step. 1.2×105 cells were dispensed to
individual wells of an opaque 96-well plate (Perkin Elmer, 6005299) and
10 µM coelenterazine h (Nanolight Technology) was added to each well.
After a 3 min incubation, assays were performed using a Synergy 2
microplate reader (Biotek) equipped with emission filters for rLuc8 (485/
20 nm) and Venus (528/20 nm). Basal BRET was measured for 1 min, then
EDN1 (1 μM final concentration) was added to wells and the response was
measured for 5 min. BRET was monitored by detecting 485/20 nm and 528/
20 nm emissions every 2 s using automatic filter switching. Normalized
BRET values were calculated by dividing the acceptor emission (Venus;
528/20 nm) by the donor emission (rLuc8; 485/20 nm). Normalized BRET
values were then converted to ΔBRET values using the equation:
ΔBRET=BRETt−BRETbasal/BRETbasal, where BRETt is the BRET value
at any given time point, and BRETbasal is the average BRET value of the 1min basal recording prior to EDN1 addition. ΔBRET traces were fit to a
single-phase exponential curve to quantify the maximum response values.
Each experimental condition was performed at least three times in triplicate
wells. Curve fitting and statistical analysis were conducted using Prism
(GraphPad).
Transcriptional reporter assay

HEK293T (CRL-11268) and HEK293 (CRL-1573) cells were purchased
from American Type Culture Collection (ATCC) and were thus not
authenticated. Cells were tested and confirmed to be mycoplasma free. Cells
were maintained in Dulbecco’s Modified Eagle Medium (DMEM)
(Corning) supplemented with 10% fetal bovine serum in a tissue culture
incubator at 37°C and 5% CO2 in the absence of antibiotics. Transfections
were performed with X-tremeGENE 9 (Roche), using a 3:1 ratio of
X-tremeGENE 9 to plasmid DNA.
Time-lapse imaging assay

HEK293T cells were seeded at 6×105 cells per dish in glass bottom dishes
(MatTek) coated with poly-D lysine (100 μg/ml, Millipore Sigma) and
co-transfected with EDNRA, GFP-C1A and wild-type PLCB4 or PLCB4
p.Arg621His at a 2:1:1 ratio (500:250:250 ng). After 6 h, growth media was
replaced with serum-free DMEM and incubated overnight. 24-36 h after
transfection, time-lapse imaging was performed using a Leica TCS SP5
confocal microscope and 63× oil objective. Images were taken in 30 s
intervals for a total of 12 min. First, basal reporter activity was imaged for
2 min, then stimulated with EDN1 and imaged for 10 min. To prevent
subjective bias, the experimental conditions for the acquired images were
masked for subsequent analysis. Individual cells were chosen for analysis
only if the fluorescence intensity of the reporter was below saturation and the
cell boundaries were clearly defined. To quantify the change in membrane
fluorescence in individual cells, we identified the first time-lapse frame
in which translocation was observed. The plot profile tool in Image J was
then used to draw a line across the cell to obtain the average fluorescence
intensity in the cytoplasm (Fcyto) and plasma membrane (Fpm). The
following equation was then used to determine the relative change in
membrane fluorescence: ΔFpm=(Fpm−Fcyto)/Fcyto (Oancea et al., 1998).
Gaussian fitting of the histogram was performed using Prism (GraphPad),
with statistical significance determined by chi-square test for trends
in Prism.
Bystander bioluminescence resonance energy transfer
(BRET) assay

HEK293T cells were seeded at 1.2×106 cells per well in a six-well tissue
culture dish and co-transfected with the vectors expressing EDNRA, rLuc8C1A, Lyn-Venus and wild-type PLCB4 or the indicated PLCB4 mutants at
a 4:1:1:2 ratio (1000:250:250:500 ng). After 24 h, growth medium was
replaced with serum-free DMEM and, 12 h later, cells were dissociated
in EDTA-free PBS (Thermo Fisher Scientific), pelleted by centrifugation
(500 g) and resuspended in reaction buffer (Tyrode’s Salts with 0.1%

HEK293 cells were seeded at 5×105 cells per well in a 12-well tissue culture
dish and co-transfected with SRE:luc2P, Gq p.Gln209Leu and wild-type
PLCB4 or the indicated PLCB4 mutant at a 2:1:1 ratio (500:250:250 ng).
After 6 h, growth media was replaced with serum-free DMEM. 12 h later,
cells were dissociated with EDTA-free PBS, pelleted by centrifugation
(500 g), and resuspended in serum-free DMEM. 60,000 cells were
dispensed to individual wells in an opaque 96-well plate, and an
equivalent volume of ONE-Glo Luciferase substrate (Promega) was added
to each well. After a 3 min incubation, luminescence was measured using a
Synergy 2 microplate reader. Each experimental condition was performed at
least three times in triplicate wells. Statistical analysis was conducted using
Prism.
Immunofluorescence and image acquisition

HEK293T cells were seeded at 5×105 cells per well on poly-D lysine-coated
(100 μg/ml) glass coverslips in a six-well tissue culture dish and transfected
with wild-type PLCB4 or the indicated PLCB4 mutant. After 36 h, cells
were fixed in 4% paraformaldehyde in PBS for 15 min at room temperature,
permeabilized with 0.1% Triton X-100 in PBS for 10 min at room
temperature, then incubated for 1 h at room temperature in blocking buffer
(5% goat serum and 0.1% Tween 20 in PBS). Cells were then incubated with
a mouse anti-Myc (9e10) primary antibody (Thermo Fisher Scientific,
MA1-980) in blocking buffer overnight at 4°C. Cells were washed three
times for 1 h each with 0.1% Tween 20 in PBS and then incubated with
Alexa Fluor 488 goat anti-mouse IgG1(γ1) secondary antibody (Thermo
Fisher Scientific, A21121) for 1 h at room temperature. Cells were then
washed and mounted in ProLong Gold antifade reagent (Thermo Fisher
Scientific). Cells were imaged using a Leica TCS SP8 confocal microscope
and 63× oil objective. Images were taken as z-stacks and are presented as
maximum projection images.
Western blot analysis

Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer
containing 1× Complete Protease Inhibitor (Roche) and cleared by
centrifugation. Cleared lysates were mixed with Laemmli buffer [25%
glycerol, 5% β-mercaptoethanol, 2% sodium dodecyl sulfate, 0.01%
Bromophenol Blue, 62.5 mM Tris ( pH 6.8)] and boiled for 10 min.
Lysates were then resolved with 10% SDS-PAGE and transferred to
Immobilon PVDF membrane (Millipore Sigma). Membranes were
incubated in blocking buffer [5% milk in TBST: 25 mM Tris ( pH 7.2),
150 mM NaCl, 2.7 mM KCl, 0.1% Tween 20] for 1 h at room temperature,
and then with mouse anti-FLAG (M2) (Millipore Sigma, cat. F1804) or
mouse anti-alpha tubulin (12G10) (Developmental Studies Hybridoma
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Bank) primary antibody in blocking buffer at 4°C overnight. Membranes
were washed with TBST and incubated with HRP-conjugated anti-mouse
(Cell Signaling) secondary antibody for 1 h at room temperature.
Membranes were then washed with TBST, incubated with SuperSignal
West Pico Chemiluminescent Substrate (Thermo Fisher Scientific) and
imaged with a ChemiDoc Imaging System (Bio-Rad Laboratories). Band
intensity was quantified using the Image Lab software (Bio-Rad
Laboratories). Quantified band intensities for FLAG were normalized to
α-tubulin (loading control), and normalized values were then expressed as a
percentage of wild-type PLCB4. Statistical analysis was conducted using
Prism.

(2000 ng/μl), Alt-R Cas9 nuclease (500 ng/μl), gRNA (600 ng/μl) and
10 μl Opti-MEM reduced serum media (Millipore Sigma). This mixture was
transferred to an electroporation cuvette (Harvard Apparatus) with a 1 mm
gap electrode. Using a BTX ECM830 Square-pulse Electroporator (Harvard
Apparatus), embryos were electroporated with six 3 ms pulses of 30 V at
100 ms intervals. Electroporated zygotes were immediately implanted in
pseudopregnant dams via oviduct transfer, designating the transfer/
implantation date as embryonic day 0.5 (E0.5). Embryos were then
collected at E18.5 and fixed in 4% paraformaldehyde.

All experiments involving mice were approved by the Institutional Advisory
and Use Committee at The Jackson Laboratory (Protocol 20028).
Design and sourcing of guide RNA and donor oligos

Candidate guide RNA (gRNA) sequences for CRISPR/Cas9 editing were
selected on the basis of off-target and efficiency scores, as well as proximity
to the orthologous human variant site. Based on these criteria, the guide
Plcb4-R621H-Rev 5′ GGCCTCCCTTGGGGTAAATGCGG 3′ (reverse
strand) was selected as the gRNA sequence for Plcb4. This sequence was
used to create the unique CRISPR RNA (crRNA), which also contains a
16-nucleotide complementary sequence to the common tracrRNA (trRNA).
A 120 bp donor oligonucleotide [single-stranded DNA (ssDNA)] harboring
the Plcb4 mutation c.G1862A (second bolded underlined nucleotide) was
designed to create the p.Arg621His variant GTTCTCTGTTGTGCGTTCGCCTTGGCTGCTCTTGGATTTCCTTAATCAGTTACCCAGTTACAATAAGCGACAAATGAGTCACATTTACCCCAAGGGAGGCCGAGTTGATTCCAGTAATT (forward strand). A silent mutation in the
PAM sequence (first bolded underlined nucleotide) was included to reduce
potential recutting. The crRNA, trRNA and ssDNA were sourced from
Integrated DNA Technologies (IDT).
Guide RNA annealing and ribonucleoprotein complex formation

Plcb4-R621H crRNA was annealed with trRNA following IDT Alt-R
System protocols. Briefly, both components were resuspended at 100 μM in
IDT Duplex Buffer, combined in equal amounts, heated to 95°C for 5 min
and allowed to cool passively to room temperature. Following this annealing
step, the concentration of annealed guide RNA was assayed by NanoDrop.
The CRISPR:tracr guide RNA hybrid was complexed with Alt-R Cas9 at
37°C for 15 min in a thermocycler.
Guide RNA testing in blastocyst culture

Prior to Plcb4-R621H F0 experiments, the editing efficiency of the gRNA
and ssDNA donor were first tested ex vivo. Zygotes were harvested from
naturally mated super-ovulated C57BL/6NJ females and electroporated with
the ssDNA donor (1000 ng/μl) and the ribonucleoprotein complex
containing Alt-R Cas9 nuclease (250 ng/μl) and gRNA (300 ng/μl).
Following electroporation, zygotes were cultured in Sydney Cleavage
Medium (COOK Medical) at 37°C in 5% CO2 in a benchtop incubator
(COOK Medical). After 96 h, individual blastocysts were collected and
lysed in DNA extraction buffer (25 mM NaOH and 0.2 mM EDTA) at 95°C
for 15 min, and then neutralized with an equal volume of 40 mM Tris HCl.
The extracted DNA was used to PCR amplify the editing site of the Plcb4
genomic locus using the primers 5′ CAGACGTACATGCGTTGTTTCC 3′
and 5′ TTTCACATGGCAGCTTCCTTTA 3′, generating a product size of
423 bp. The amplification product was assessed for editing efficiency by
Sanger sequencing. The selected gRNA sequence and ssDNA donor yielded
a sufficient editing rate (Fig. S2) and were subsequently used to generate F0
mice.

Genomic DNA was extracted from embryonic tail tips and the editing site of
the Plcb4 locus was PCR amplified using the primers described above that
were used to test editing efficiency. PCR products were then analyzed by
Sanger sequencing. Sequence traces were first manually curated for
preliminary scoring of homology-directed repair (HDR) and nonhomologous end joining (NHEJ) events. Sequences were also analyzed
using the Inference of CRISPR Editing (ICE) deconvolution tool from
Synthego (https://ice.synthego.com; Synthego Performance Analysis, ICE
Analysis. 2019. v2.0.).
Skeletal analysis

E18.5 embryos were collected, fixed and stained with Alizarin Red and
Alcian Blue to visualize bone and cartilage, respectively, as previously
described (Ruest et al., 2004).
µCT analysis of CRISPR/Cas9 F0 embryos

Fixed F0 embryos were incubated in stabilization buffer (0.1% bisacrylamide, 4.5% acrylamide, 4% paraformaldehyde, 0.3% VA044 and
0.05% saponin) for 72 h at 4°C. Samples were then flushed with nitrogen
gas and polymerized at 37°C for 3 h. After removal from cured hydrogel,
embryos were embedded in 1% agarose in 5 ml polypropylene transfer tubes
(Fisher Scientific) and scanned with a Skyscan 1172 microCT with a 0.5 μm
aluminum filter (Bruker BioSpin) using the following parameters: 13.49 µm
resolution, 100 kV, 100 µA, 4400 ms exposure, 0.3° step size, 360° rotation
and nine-frame averaging.
Additional embryos that had been used for skeletal staining (above) were
also imaged using µCT. These embryos were placed individually in
polypropylene cryovial tubes filled with PBS and scanned with a Skyscan
1275 microCT (Bruker BioSpin) using the following parameters: 8.5 µm
resolution, 40 kV, 200 µA, 45 ms exposure, 0.3° rotation step, 180° imaging
and four-frame averaging. Raw images from all scans were reconstructed
using NRecon software (Bruker BioSpin).
Reconstructed scan data were imported into Drishti volume exploration
software (version 2.63) (Limaye, 2012) for 3D rendering. Rendering
settings were optimized for visualization and phenotypic assessment of
mineralized tissues. To visualize the pterygoid/basisphenoid complex in
isolation, two operations were performed on the Drishti-rendered volumes.
Initially clip planes were used to exclude the bulk of the cranial bone around
the complex. The MOP-carve function was then used to remove remaining
bone from around the complex. To make rotational movies of the complexes
to aid inspection, the Keyframe Editor function of Drishti was employed.
For this, a new rotational axis was assigned for each volume and the initial
keyframe set to mark the starting view of the rotation. The desired end of the
rotation was set using the Bricks Editor function and a second keyframe set.
All interpolated keyframes between the starting and ending keyframe were
then saved as an image sequence in png format. Image sequences were then
opened in Adobe Photoshop 2020 and rendered in mp4 format. Selected
images from the renderings were saved and optimized for contrast, color and
background using Adobe Photoshop.
Human CT scanning

Zygote electroporation and F0 embryo harvest

All mouse procedures were conducted according to national and
international guidelines (AALAC and IACUC) and have been approved
by The Jackson Laboratory Animal Care and Use Committee. For
electroporation, zygotes from C57BL/6NJ mice were harvested and
placed in a 20 µl droplet comprised of 10 μl TE buffer with ssDNA donor

All studies were approved by the University of Washington Institutional
Review Board (10926). Maxillofacial computed tomography scans were
obtained for clinical purposes from a child with ARCND2 and an agematched child with normal skull base anatomy scanned for an unrelated
clinical indication. Scans were performed using a Toshiba Aquilion 16, GE
Lightspeed VCT or Siemens Definition CT scanner. All scanners are
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helical, multi-slice CT units. Scans were performed with 0.5 s rotation time,
no gantry tilt, pitch varying from 0.55 to 1 and tube voltage between 100 and
120 kVp. The Siemens scanner used iterative reconstruction, tube current
modulation and automatic kVp selection. CT images were deidentified and
volume-rendered 3D reconstruction performed using a Siemens syngo.via
workstation.
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Fig. S1. Transfection of exogenous PLCB4 is not necessary for EDN1 to stimulate a DAG
reporter response. Cells were transfected with GFP-C1, EDNRA, and empty vector
(pcDNA3.1) and imaged before (0 seconds; t=0) and after addition of EDN1. Cytoplasm to
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membrane translocation of GFP-C1 was observed within the first imaging frame following
EDN1 addition (30 seconds; t=30).
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64 blastocysts were collected and genomic DNA submitted for Sanger sequencing. The bars
represent the type of editing that was detected.
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Fig. S2. Types of targeting observed in Plcb4 CRISPR blastocysts. After electroporation,
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Movie 2. Rotating µCT images of the digitally-dissected basisphenoid/pterygoid complex from
E18.5 control (top) and Plcb4KI/KI (bottom) embryos.
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Movie 1. Rotating µCT images of E18.5 control (left) and Plcb4KI/KI (right) embryos.

